
Iron and Biological Ageing
To solve the mystery of human ageing we propose to first understand it in a simpler animal. Our laboratory takes a fresh approach, using the nematode Caenorhabditis elegans with a focus on biological metal ions. Metal ions are essential for life with approximately half of all proteins using a metal ion co-factor. However, excess metal ions can be highly toxic. Organs such as the brain accumulates iron through life, which may contribute to disease risk.
Aims
To explore why the handling of redox-active iron fatigues with age, and creates a toxic, pro-ageing biochemistry and drives cell death. In addition, this project will
- Characterise the cellular consequences of age-dependent iron changes
- Investigate cell type specific restoration of iron homeostasis to identify where iron toxicity occurs and if and how it spreads
Age is the single biggest risk factor for major neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. How ageing drives disease susceptibility is a fundamental but poorly understood question.
To solve the mystery of human ageing we propose to first understand it in a simpler animal. Our laboratory takes a fresh approach, using the nematode Caenorhabditis elegans with a focus on biological metal ions. Metal ions are essential for life with approximately half of all proteins using a metal ion co-factor. However, excess metal ions can be highly toxic. Organs such as the brain accumulates iron through life, which may contribute to disease risk.
Figure: X-ray Fluorescence micrograph of iron within an intact C. elegans specimen.
Latest Florey news for Neuroegenerative Diseases
-
Alzheimer’s Disease, Parkinson’s, STEM
Current & emerging treatments for Parkinson’s disease: from bedside to bench
In 2014, conservative estimates indicated there were just under 70,000 people living with Parkinson’s in Australia making it the most common major movement disorder and second highest prevalence neurodegenerative condition with only dementia exceeding it.
-
Alzheimer’s Disease, Parkinson’s, STEM
Minimally invasive blood test for Alzheimer’s disease announced
Scientists from Japan and Australia have teamed up to develop and validate a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials.
Support us
Brain health affects all Australians. You can support our research by making a donation or a bequest.
- Give todayDonate now
- Pledge over timeJoin our brains trust
- Plan for the futureMake a gift in your will
Newsletter
Latest breakthroughs, news, events & more.